3Klinman DM, Steinberg AD. Systemic autoimmune diseases arises from polyclonal B cell activation. J Exp Med, 1987,165:1755.
4Lacki JK, Sambroski W, Mackiewicz SH. Interleukin-10 and inlerleukin-6 in lupus erythematosus and rheumatoid arthritis, correlation with acute phase proteins. Clin Rheumatol, 1997,16:275.
5Park YB, Lee SK, Kim DS, et al. Elevated inlerleukin-10 levels correlated with disease activity in systemic lupus erythematosus. Clin Exp Rhematol, 1998, 16:183.
6Groux H, Bigler M, de Vries JE, et al. Inhibitory and stimulatory effects of IL-10 on human CD8^+T cells. J Immunol, 1998,160:3188.
7Fouqueray B, Boutant V, Philippe C, et al. Mesangial cell-derived interleukin-10 modulates mesangial cell response to lipopolysaccharide. Am J Pathol, 1995,147( 1 ) : 176.
8Niemir ZI, Ondracek M, Dworacki G, et al. In situ upregulation of IL-10 reflects the activity of human glomerulonephritides. Am J Kidney Dis,1998,32:80.
9Beebe AM, Cua DJ, de Waal Malefyt R. The role of interleukin-10 in autoimmune disease: systemic lupus erythematosus ( SLE ) and multiple sclerosis (MS). Cytokine & Growth Factor Reviews,2002,13:403.
5[5]Park YB,Lee SK,Kim DS,et al.Elevated interleukin-10 levels corre-lated with disease activity in systemic lupus erythematosus[J].Clin Exp Rhe-matol,1998,(16):183.
6Elenkov IJ,Webster E,Papanicolaou DA,et al.Histamine potently suppresses human IL-12 and situmulates IL-10 produaction via H2 receptors.J Immunol 1998;161:2586-2593.
7Wang CR,Liu ST,Liu MF,et al.The effect of allergen immunotherapy on in vitro IL-4 and IFN-gamma production by peripheral mononuclear cells in house dust-sensitive Chinese patients with bronchial asthma.Asian Pac J Allergy Immunol 1999;17:249-254.
9Leandro MJ,Edwards JC* Cambridge G,et al.An open study of B lymphocyte depletion.in systemic lupus erythematosus[J].Arthritis Rheum,2002,46(10):2673-2677.
10Raman C.CD5,an important regulator of lymphocyte selection and immune tolerance[J].Immunol Res,2002,26(1/2/3):255-263.
